Our experienced professionals tailor each session to meet your specific health and skin goals
Tirzepatide is a dual GIP/GLP-1 receptor agonist with a 5-day half-life, meaning it takes approximately 25 days (3-4 weeks) for the medication to be substantially eliminated from your body after your final injection
It reduces pro-inflammatory cytokines like TNF and IL6 while enhancing structural repair
Collagen Synthesis Regulation BPC-157 appears to influence genes associated with collagen production , which is foundational to: ligament studies tendon regeneration assays skin & dermal cellular repair models This is one of the reasons the peptide is heavily studied within orthopedic-related biochemical research
Stop and Seek Help If Any signs of allergic reactionstop immediately and get medical help Persistent metallic taste that doesn't go away (possible copper excess) Injection site reactions that spread, worsen, or show signs of infection Nausea or stomach upset that persists beyond the first few days Unusual skin discoloration away from injection sites Your treatment goals have been achieved and you're in maintenance mode GHK-Cu is a research compound, not an FDA-approved medication
The most important factor for any research protocol is consistency, so administering it at the same time each day is recommended
